Latest news
Arrowhead Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $110.2, Implies 23% Upside - TradingViewTradingView · Wed, 05 Aug 2026 09:20:04 GMTArrowhead Pharmaceuticals Inc (ARWR) (Q3 2026) Earnings Call Highlights: Strong Phase III Data ... - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 05:05:00 GMTArrowhead Pharmaceuticals Acquires FDA Priority Review Voucher - BioSpaceBioSpace · Wed, 05 Aug 2026 02:46:50 GMTArrowhead Pharmaceuticals (NASDAQ:ARWR) Announces Quarterly Earnings Results - MarketBeatMarketBeat · Wed, 05 Aug 2026 00:14:20 GMTArrowhead Pharmaceuticals Q3 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 22:03:56 GMTArrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results - Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals, Inc. · Tue, 04 Aug 2026 21:11:19 GMTArrowhead Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 21:01:32 GMTArrowhead Pharmaceuticals Fiscal Q3 Loss Widens, Revenue Rises - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 20:12:07 GMT